Robert E. Merritt, MD, Reiko E. Yamada, BA, Nabil Wasif, MD, Ronald G

Slides:



Advertisements
Similar presentations
Volume 114, Issue 6, Pages (December 1998)
Advertisements

Adenoviral herpes simplex virus thymidine kinase gene therapy in an orthotopic lung cancer model  Mari Fukunaga, MD, Shinzo Takamori, MD, Akihiro Hayashi,
Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin  Todd K. Rosengart, MD, Kurt.
Combretastatin A-4 prodrug inhibits growth of human non–small cell lung cancer in a murine xenotransplant model  Arnd S Boehle, MD, Bence Sipos, MD, Ursula.
Naoki Fujimura, MD, PhD, Jiang Xiong, MD, PhD, Ellen B
In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia  Geoffrey O. Ouma,
In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies  Ali Mahtabifard,
Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis  Dao M Nguyen, MD, Dominique.
RANKL Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non–Small-Cell Lung Cancer Bone Metastases  Robert E. Miller,
Latency-Associated Peptide Prevents Skin Fibrosis in Murine Sclerodermatous Graft- Versus-Host Disease, a Model for Human Scleroderma  Yan Zhang, Laura.
Rapamycin is an effective inhibitor of human renal cancer metastasis1
Inhibition of Platelet GPIbα and Promotion of Melanoma Metastasis
Dino J. Ravnic, DO, Moritz A. Konerding, MD, Juan P
The SCF/KIT Pathway Plays a Critical Role in the Control of Normal Human Melanocyte Homeostasis  James M. Grichnik, James A. Burch, James Burchette, Christopher.
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression by Rosalba Salcedo, Maria Lourdes.
Volume 71, Issue 3, Pages (February 2007)
Robert A. Brenes, MD, Caroline C
Regulation of Human Melanoma Growth and Metastasis by AGE–AGE Receptor Interactions  Riichiro Abe, Tadamichi Shimizu, Hiroshi Sugawara, Hirokazu Watanabe,
Combination of stromal-derived factor-1α and vascular endothelial growth factor gene- modified endothelial progenitor cells is more effective for ischemic.
Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent manner. Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent.
Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy  Che-Hsin Lee, Chao-Liang Wu, Yun-Sheng.
Effect of Prepro-Calcitonin Gene-Related Peptide–Expressing Endothelial Progenitor Cells on Pulmonary Hypertension  Qiang Zhao, MD, Zixiong Liu, MD, Zhe.
Adenoviral herpes simplex virus thymidine kinase gene therapy in an orthotopic lung cancer model  Mari Fukunaga, MD, Shinzo Takamori, MD, Akihiro Hayashi,
Volume 17, Issue 2, Pages (February 2009)
Volume 16, Issue 6, Pages (June 2008)
Volume 3, Issue 4, Pages (April 2001)
Pravastatin Improves Remodeling and Cardiac Function After Myocardial Infarction by an Antiinflammatory Mechanism Rather than by the Induction of Angiogenesis 
Volume 15, Issue 12, Pages (December 2007)
Attenuation of early atherosclerotic lesions by immunotolerance with β2 glycoprotein I and the immunomodulatory effectors interleukin 2 and 10 in a murine.
Volume 18, Issue 10, Pages (October 2010)
Volume 127, Issue 3, Pages (September 2004)
Volume 24, Issue 12, Pages (December 2016)
Regression of Established AB1 Murine Mesothelioma Induced by Peritumoral Injections of CpG Oligodeoxynucleotide Either Alone or in Combination with Poly(I:C)
Orthotopic Lung Cancer Murine Model by Nonoperative Transbronchial Approach  Takahiro Nakajima, MD, PhD, Takashi Anayama, MD, PhD, Yasushi Matsuda, MD,
Pulmonary Lymphangioma
Therapeutic angiogenesis induced by local autologous bone marrow cell implantation  Kimikazu Hamano, MD, Tao-Sheng Li, MD, Toshiro Kobayashi, MD, Ken Hirata,
Morgan D. Schulz, MD, Kimberly Ann V. Zubris, PhD, Jacqueline E
Immuno-gene therapy with interferon-β before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma  Robert.
Gene Correction Reduces Cutaneous Inflammation and Granuloma Formation in Murine X-Linked Chronic Granulomatous Disease  W. Scott Goebel, Lawrence A.
Single-dose rosuvastatin ameliorates lung ischemia–reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage.
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion 
Cisplatin augments cytotoxic T-lymphocyte–mediated antitumor immunity in poorly immunogenic murine lung cancer  Robert E Merritt, MD, Ali Mahtabifard,
Volume 10, Issue 6, Pages (December 2004)
Einar K. Rofstad, Bjørn A. Graff  Journal of Investigative Dermatology 
Volume 7, Issue 2, Pages (February 2003)
Volume 18, Issue 3, Pages (March 2010)
Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin  Todd K. Rosengart, MD, Kurt.
Volume 16, Issue 6, Pages (June 2008)
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Interleukin-18 and the Costimulatory Molecule B7-1 Have a Synergistic Anti-Tumor Effect on Murine Melanoma; Implication of Combined Immunotherapy for.
Reconstitution of Blood Supply of the Denuded Bronchial Stump
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models  Fabrice Le Boeuf, Simon Gebremeskel,
Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines  Wei Zhang, PhD, Michael.
Volume 2, Issue 6, Pages (December 2002)
Volume 15, Issue 3, Pages (March 2009)
Volume 15, Issue 1, Pages (January 2009)
Up-regulation of vascular endothelial growth factor mrna and angiogenesis after transmyocardial laser revascularization  Keith A Horvath, MD, Elaine Chiu,
Volume 20, Issue 1, Pages (January 2012)
Volume 12, Issue 4, Pages (October 2005)
Volume 6, Issue 3, Pages (September 2002)
Volume 17, Issue 10, Pages (October 2009)
Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts  Bryce D Beseth, MD, Robert B Cameron, MD, Pamela Leland,
Volume 8, Issue 2, Pages (August 2003)
Volume 6, Issue 5, Pages (November 2002)
Sindbis Viral Vectors Transiently Deliver Tumor-associated Antigens to Lymph Nodes and Elicit Diversified Antitumor CD8+ T-cell Immunity  Tomer Granot,
Volume 23, Issue 3, Pages (March 2015)
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
Volume 16, Issue 10, Pages (October 2008)
Volume 7, Issue 2, Pages (February 2003)
Engraftment of Bone Marrow–derived Stem Cells to the Lung in a Model of Acute Respiratory Infection by Pseudomonas aeruginosa  Joanna Rejman, Carla Colombo,
Presentation transcript:

Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma  Robert E. Merritt, MD, Reiko E. Yamada, BA, Nabil Wasif, MD, Ronald G. Crystal, MD, Robert J. Korst, MD  The Annals of Thoracic Surgery  Volume 78, Issue 3, Pages 1042-1051 (September 2004) DOI: 10.1016/j.athoracsur.2004.03.021

Fig 1 The combination of intratumoral AdPEDF and Adsflt-1 inhibits tumor growth and prolongs survival more effectively than either strategy alone in a flank tumor model of malignant pleural mesothelioma. Seven days after AB-12 flank tumor initiation, BALB/c mice were randomized to five groups: AdPEDF plus Adsflt-1 (♦, n = 8; 5 × 1010 particles of each vector); Adsflt-1 alone (○, n = 8); AdPEDF alone (▴, n = 8); a negative control vector (AdNull, □, n = 8); or phosphate-buffered saline (PBS, ■, n = 8). All animals received intratumoral injections and the total vector dose per mouse was 1011 particles suspended in 100 μL PBS for all groups in which vectors were administered. The tumor area was assessed every 2 to 3 days with microcalipers, and statistical analysis was performed 25 days after tumor initiation. The mice were sacrificed when they appeared moribund or when the largest tumor diameter reached 15 mm. Arrows indicate time point of vector (or PBS) administration. (A) Tumor area for AB-12 mesothelioma flank tumors in BALB/c mice. The data points represent the mean tumor area ± SEM. (B) Survival for BALB/c mice bearing AB-12 mesothelioma flank tumors. (AdPEDF = adenovirus vector encoding the human pigment epithelium-derived factor; Adsflt-1 = adenovirus vector encoding the human soluble vascular endothelial growth factor receptor-1.) The Annals of Thoracic Surgery 2004 78, 1042-1051DOI: (10.1016/j.athoracsur.2004.03.021)

Fig 2 Immunohistochemical analysis of flank tumor blood vessel density after intratumoral administration of AdPEDF and Adsflt-1. Seven days after AB-12 flank tumor initiation, BALB/c mice were randomized to one of five groups: AdPEDF plus Adsflt-1; Adsflt-1 alone; AdPEDF alone; a negative control vector (AdNull); or phosphate-buffered saline (PBS). All animals received intratumoral injections and the total vector dose was 1011 particles suspended in 100 μL PBS for all groups in which vectors were administered. The tumors were harvested 10 days after vector therapy and frozen sections were stained immunohistochemically for CD31. The dark staining represents endothelial cells within the AB-12 flank tumors. (A) PBS (n = 8). (B) AdNull (n = 8). (C) Adsflt-1 (n = 8). (D) AdPEDF (n = 8). (E) Adsflt-1 plus AdPEDF (n = 8; 5 × 1010 particles of each vector). (AdPEDF = adenovirus vector encoding the human pigment epithelium-derived factor; Adsflt-1 = adenovirus vector encoding the human soluble vascular endothelial growth factor receptor-1.) The Annals of Thoracic Surgery 2004 78, 1042-1051DOI: (10.1016/j.athoracsur.2004.03.021)

Fig 3 Tumor blood vessel density is significantly diminished after the combined administration of AdPEDF and Adsflt-1. Metamorph digital image analysis of the tumor sections from Figure 2 was performed as described in the Methods section. Five random ×20 fields of AB-12 tumor sections were used to quantify tumor vessel density (number of vessels/μm2). The tumor vessel density is reported as the mean number of CD31-positive vessels/μm2 ± SEM. (AdNull = a negative control vector; AdPEDF = adenovirus vector encoding the human pigment epithelium-derived factor; Adsflt-1 = adenovirus vector encoding the human soluble vascular endothelial growth factor receptor-1; PBS = phosphate-buffered saline.) The Annals of Thoracic Surgery 2004 78, 1042-1051DOI: (10.1016/j.athoracsur.2004.03.021)

Fig 4 Thoracic tumor burden after intrapleural administration of AdPEDF and Adsflt-1 in an orthotopic model of malignant pleural mesothelioma. BALB/c mice underwent intrapleural instillation of AB-12 mesothelioma cells as well as phosphate-buffered saline (PBS), a negative control vector (AdNull), AdPEDF alone, Adsflt-1 alone, or AdPEDF plus Adsflt-1. Vectors were instilled into the pleural cavity at the same time as the tumor cells and the total vector dose was 1011 particles suspended in 100 μL PBS for all groups in which vectors were administered. On day 14, the animals were sacrificed and necropsies were performed to assess the presence of tumor in the pleural cavity. In the photographs, tumor deposits are circled. (A) PBS (n = 5). (B) AdNull (n = 4). (C) Adsflt-1 (n = 4). (D) AdPEDF (n = 4). (E) Adsflt-1 plus AdPEDF (n = 5; 5 × 1010 particles of each vector); this panel represents the only animal with grossly visible tumor in the pleural cavity in the combination group. (AdPEDF = adenovirus vector encoding the human pigment epithelium-derived factor; Adsflt-1 = adenovirus vector encoding the human soluble vascular endothelial growth factor receptor-1; Th = thymus; H = heart; L = lungs.) The Annals of Thoracic Surgery 2004 78, 1042-1051DOI: (10.1016/j.athoracsur.2004.03.021)

Fig 5 Quantitative assessment of thoracic tumor burden after intrapleural administration of AdPEDF and Adsflt-1 in an orthotopic model of malignant pleural mesothelioma. Tumor deposits were excised from the animals in the experiment described in Figure 4 and weighed. Each data point represents an individual mouse, whereas the horizontal bars depict the mean weights. (AdNull = a negative control vector; AdPEDF = adenovirus vector encoding the human pigment epithelium-derived factor; Adsflt-1 = adenovirus vector encoding the human soluble vascular endothelial growth factor receptor-1; PBS = phosphate-buffered saline.) The Annals of Thoracic Surgery 2004 78, 1042-1051DOI: (10.1016/j.athoracsur.2004.03.021)

Fig 6 The combination of intrapleural AdPEDF and Adsflt-1 enhanced survival of tumor-bearing mice compared with either vector alone in an orthotopic model of malignant pleural mesothelioma. BALB/c mice underwent intrapleural instillation of AB-12 mesothelioma cells as well as phosphate-buffered saline (PBS, ■, n = 6); a negative control vector (AdNull, □, n = 6); AdPEDF alone (▴, n = 6); Adsflt-1 (○, n = 6); or AdPEDF plus Adsflt-1 (♦, n = 6; 5 × 1010 particles of each vector). Vectors were instilled into the pleural cavity at the same time as the tumor cells and the total vector dose was 1011 particles suspended in 100 μL PBS for all groups in which vectors were administered. The mice were observed daily and survival was recorded. (AdPEDF = adenovirus vector encoding the human pigment epithelium-derived factor; Adsflt-1 = adenovirus vector encoding the human soluble vascular endothelial growth factor receptor-1.) The Annals of Thoracic Surgery 2004 78, 1042-1051DOI: (10.1016/j.athoracsur.2004.03.021)

Fig 7 Effect of intrapleural instillation of AdPEDF and Adsflt-1 on lung histology in tumor-free BALB/c mice. Phosphate-buffered saline (PBS), a negative control vector (AdNull), Adsflt-1, or AdPEDF were instilled into the right pleural space of normal BALB/c mice. The total vector dose was 1011 particles suspended in 100 μL PBS for all groups in which vectors were administered. After 21 days, the animals were sacrificed and the lungs were fixed with 4% paraformaldehyde, embedded in paraffin, and stained with hematoxylin & eosin. A separate group of normal mice underwent intratracheal instillation of porcine pancreatic elastase (30 μg in 50 μL PBS) 28 days before sacrifice to serve as a positive control for the measurement of pulmonary emphysema. (A) PBS. (B) AdNull. (C) Adsflt-1. (D) AdPEDF. (E) Elastase. (AdPEDF = adenovirus vector encoding the human pigment epithelium-derived factor; Adsflt-1 = adenovirus vector encoding the human soluble vascular endothelial growth factor receptor-1.) The Annals of Thoracic Surgery 2004 78, 1042-1051DOI: (10.1016/j.athoracsur.2004.03.021)

Fig 8 Intrapleural instillation of AdPEDF or Adsflt-1 does not increase interalveolar septal distance in normal mice. As a measure of pulmonary emphysema, the mean linear intercept was calculated from the lung sections of the animals depicted in Figure 7 as described in Methods. The mean linear intercept is determined by dividing the total length of a line drawn across a lung section by the total number of alveolar intercepts encountered. Bars represent the mean of six random measurements. Higher mean linear intercept values reflect greater interalveolar septal distance, a microscopic characteristic of pulmonary emphysema. (AdNull = a negative control vector; AdPEDF= adenovirus vector encoding the human pigment epithelium-derived factor; Adsflt-1 = adenovirus vector encoding the human soluble vascular endothelial growth factor receptor-1; PBS = phosphate-buffered saline.) The Annals of Thoracic Surgery 2004 78, 1042-1051DOI: (10.1016/j.athoracsur.2004.03.021)